Cure My Disease

Don't miss your cure!

 Log in / Sign up

Faster brain zaps may boost brain power, study finds

NCT ID NCT07431697

Knowledge-focused Sponsor: Ecole Polytechnique Fédérale de Lausanne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of brain stimulation called high-gamma iTBS in 22 healthy adults. The goal was to see if it could increase brain activity more than the standard method. Using brain scans and muscle measurements, the researchers found that the new method produced stronger and more consistent effects. This is early research that may help develop better treatments for brain disorders in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intermittent theta burst stimulation (iTBS) using transcranial magnetic stimulation (TMS)
What this could lead to
If this works, it could point toward more effective ways to stimulate the brain for treating conditions like depression or stroke recovery.
What could go wrong
This was a small, early study in healthy volunteers, not patients. The results may not apply to people with brain disorders, and the technique needs much more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Feb 2023

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Right handed Exclusion Criteria: * Contraindications to either TMS or MRI: Pregnant Metal implants Use of recreational drugs Neurological conditions History of seizures or epilepsy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy young participants are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy young participants

Contacts and locations

Locations

  • Campus Biotech

    Geneva, Canton of Geneva, 1202, Switzerland